Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.31982
Abstract: Key Points Question Is treatment with semaglutide associated with weight loss outcomes similar to those seen in results of randomized clinical trials? Findings In this cohort study of 175 patients with overweight or obesity, the… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Obesity"
DOI: 10.1002/oby.23371
Abstract: Modest weight loss (5%‐10%) is clinically meaningful in patients with overweight or obesity. However, greater weight loss may be required to achieve improvements in or remission of certain weight‐related complications. Therefore, this study reviewed the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Obesity"
DOI: 10.1038/s41366-022-01086-3
Abstract: Exercise is an important strategy in the management of diabetes. Experimental studies have shown that exercise acts, at least in part, by inducing the production of myokines that improve metabolic control and activate brown/beige adipose… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Diabetes Research"
DOI: 10.1155/2022/4126995
Abstract: Objective We aimed to clarify the efficacy of dapagliflozin versus liraglutide in patients with overweight or obesity and type 2 diabetes mellitus (T2DM) at the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Methods T2DM… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Circulation"
DOI: 10.1161/circ.152.suppl_3.4368652
Abstract: Introduction: Semaglutide 2.4 mg has been shown to reduce the risk and severity of cardiometabolic comorbidities (CMCs) and to improve cardiometabolic biomarkers in patients with overweight or obesity in clinical trials. However, real-world evidence in… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Primary Care & Community Health"
DOI: 10.1177/21501319221115256
Abstract: Introduction: Obesity is a major public health concern. Accurate perception of body weight may be critical to the successful adoption of weight loss behavior. The aim of this study was to determine the accuracy of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "European Journal of Medical Research"
DOI: 10.1186/s40001-025-03124-y
Abstract: Semaglutide has demonstrated potential in controlling hyperglycemia and lowering cardiovascular (CV) risk. However, its impact on arrhythmic, major CV, and renal outcomes is not well-defined. This systematic review and meta-analysis aimed to assess these effects… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0282823
Abstract: Introduction Excess body weight causes 4 million deaths annually across the world. The number of people affected by humanitarian crises stands at a record high level with 1 in 95 people being forcibly displaced. These… read more here.